Find News

Filter articles

Showing 51 to 60 of 2383 results

GE Healthcare partners with Vanderbilt University to create AI apps


US-based medical technology company GE Healthcare has entered into a five-year partnership with Vanderbilt University Medical Center to develop cancer immunotherapies using artificial intelligence.

FDA announces new measures to boost gene therapy innovation


The US Food and Drug Administration has announced new policies to advance the development of safe and effective cell and gene therapies.

Boston Scientific and Edwards settle heart valve disputes


Boston Scientific and US-based Edwards Lifesciences have agreed to settle all outstanding patent litigation between the two companies.

McGuire Woods adds three partners to life sciences team


US law firm McGuire Woods is expanding its life sciences patent litigation team with the addition of three partners in its New York office.

Sanofi collaborates with Biomunex to develop antibody therapeutics


Multinational pharmaceutical company Sanofi has entered into a licensing agreement with Paris-based biopharmaceutical company Biomunex.

Amerigen loses patent case against UCB at Federal Circuit


US-based Amerigen Pharmaceuticals has lost in its bid to prove that claims in a patent owned by biopharmaceutical company UCB were covered by a prior invention.

Plastic surgery clinic targets former employees in copyright and TM suit


A New York-based plastic surgery clinic has taken legal action against two former employees and a rival clinic for copyright infringement, trademark counterfeiting and dilution, and cybersquatting.

Surge in life sciences investment in Catalonia: report

EU, Spain10-01-2019

The number of international investors in life sciences start-ups in the Catalonia region in Spain has multiplied by ten in the last five years, according to a new report.

US Supreme Court refuses to hear appeal against ‘unclean hands’ decision


The US Supreme Court has refused to hear an appeal against a ruling that American pharmaceutical firm Merck & Co cannot collect $200 million in damages due to its misconduct during a trial.

Gilead announces licence and collaboration deal with Yuhan

South Korea, US10-01-2019

Gilead Sciences, a biopharmaceutical company based in the US, has entered into a licensing and collaboration agreement with South Korean healthcare company Yuhan.

Showing 51 to 60 of 2383 results